Industry: Medical devices & technology

Historic moment as UPC hands down two full decisions within 24 hours of each other

The Unified Patent Court has handed patentees a win and a loss in its first on-the-merits rulings

04 July 2024

UPC grants Abbott a preliminary injunction – including for Ireland

But despite a couple of recent wins, PI applicants have a losing record at the Unified Patent Court

21 June 2024

Blood oxygen, sweat and tears: the Apple Watch saga

Financially, is it worth fixing the existing generation watch or should the tech behemoth wait to make changes on the next generation watch?

29 March 2024

UPC appeal court overturns injunction in huge boost for bankrupt NanoString

First appellate PI decision comes as first instance judges largely opt to rule against preliminary sales bans

27 February 2024

Pandemic-era patent applications have levelled off a downturn in US grants

Anaqua AcclaimIP's analysis found that US companies, which earn the most US patents, increased their number of 2023 patents by 18% year-over-year

07 February 2024

Masimo v Apple Watch import ban fiasco tops 2023 developments in USITC

Chief IP officers also need to know about US International Trade Commission developments involving trade secret disputes, NPE-banning legislation, and more

05 January 2024

Highlights of US patent law in the life sciences in 2023

The US Supreme Court’s Amgen v Sanofi ruling is giving rise to more enablement challenges, while the Federal Circuit’s In re Cellect decision put a stamp on obviousness-type double patenting

19 December 2023

Delhi High Court defines enhanced therapeutic efficacy in setting aside Indian Patent Office refusal order

In a pharmaceutical prosecution case, the Delhi High Court has issued a decision that provides much-needed clarity on Section 3(d) of the Patents Act. The ruling will serve as a useful guide for prosecuting future life science patent applications.

13 December 2023

High-compensation patent litigation highlights courts’ growing willingness to award significant damages

Featured in Inside China’s IP Market: a Guide 2024

How to determine compensation amounts and effectively protect rights holders’ interests is a critical point of concern. It is therefore vital to analyse patent infringement litigation cases that have awarded high compensation and which kinds of claims and evidence have been well received by Chinese courts.

27 September 2023

10x Genomics strikes blow against NanoString in the US

IAM explores the American portions of a spat whose UPC and German actions have hogged the limelight

14 September 2023